| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide new N- and C-terminally double truncated tau molecules ("type IA, IB, IIA, and IIB tau molecules") and a method for providing these molecules, both from recombinant and biological sources, and a screening method. <P>SOLUTION: The new N- and C-terminally double truncated tau molecules ("type IA, IB, IIA, and IIB tau molecules"), the method for providing these molecules, both from recombinant and biological sources, and the screening method using these molecules in connection with Alzheimer's diagnosis and therapy are disclosed. <P>COPYRIGHT: (C)2009,JPO&INPIT |
